Ascletis Pharma shares included in Hong Kong Stock Connect eligible list
Ascletis Pharma Inc. says its ordinary shares traded on the HK Stock Exchange (HKEX:1672) have been included as eligible securities under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.
Ascletis Pharma Inc. (HKEX:1672, "Ascletis") said its ordinary shares, which trade on The Stock Exchange of Hong Kong Limited, have been included in the list of eligible securities under the Hong Kong Stock Connect on Sept. 7, 2026.